Search
for
Sort by
Research 31–60 of 652
- Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
- Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases
- Signal Mining for Non-Bleeding Adverse Event in Novel Oral Anticoagulants: A Pharmacovigilance Study Based on the FAERS Database
- Reporting on Adverse Clinical Events
- Safety profile of human papilloma virus vaccines: an analysis of the US Vaccine Adverse Event Reporting System from 2007 to 2017
- Combined hormonal contraception and venous thromboembolism
- Endocrinology of Transgender Medicine
- Use of combined oral contraceptives and risk of venous thromboembolism in young women: a nested case–control analysis using German claims data
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Contraception and the dermatologist
- Efficacy and safety of tofacitinib in patients with alopecia areata
- Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- What does the research say about androgen use and cerebrovascular events?
- A Review of hormone-based therapies to treat adult acne vulgaris in women
- Glucocorticoids and Risk of Venous Thromboembolism in Asthma Patients Aged 20–59 Years in the United Kingdom’s CPRD 1995–2015
- Evaluation and Treatment of Gender Dysphoria to Prepare for Gender Confirmation Surgery
- Alopecia areata does not increase the risk of venous thromboembolism: an All of Us case-control study
- Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US
- The Risk of Venous Thromboembolism (VTE) in Men with Benign Prostatic Hyperplasia Treated with 5-Alpha Reductase Inhibitors (5ARIs).
- Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study
- Effects Of Hormone Therapy On The Laboratory Profile Of Transgender People: A Scoping Review
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Gender‐affirming hormone therapy for transgender and gender‐diverse adults in Australia
- Understanding the role of prostaglandin E2 in regulating human platelet activity in health and disease
- Transgender health and the impact of aging and menopause
- Hormonal Therapies for Acne: A Comprehensive Update for Dermatologists
- Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
- Ottawa, Ontario, Canada, February 13–16, 2013
- Follikelhormone
- Peri-operative Antithrombotic Therapy in Hair Transplantation